Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00418353 · ClinicalTrials.gov registry record · NA

Antenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL"

A NA study, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase

NCT00418353 is a NA study that has completed, run by University of Oklahoma.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00418353, a NA study, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase

Study Summary

Antenatal corticosteroids result in substantial decrease in neonatal morbidity and mortality by specifically reducing the risk of respiratory distress syndrome, intraventricular hemorrhage and neonatal death among premature infants. No human randomized study has formally compared betamethasone and dexamethasone, the preferred corticosteroids for antenatal therapy, with regards to their effectiveness in reducing neonatal morbidities and mortality. Our objective was to compare betamethasone with dexamethasone in terms of effectiveness in reducing perinatal morbidities and mortality among preterm infants.

Interventions

  • DRUG Betamethasone(Celestone soluspan) and Dexamethasone

Trial Details

FieldValue
Start Date 2002-08
Est. Completion 2005-04
Phase NA

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT00418353

The ClinicalTrials.gov registry entry for NCT00418353 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Betamethasone(Celestone soluspan) and Dexamethasone is the first listed.

NCT00418353 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00418353 about?

NCT00418353 is a clinical study titled "Antenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL"". Antenatal corticosteroids result in substantial decrease in neonatal morbidity and mortality by specifically reducing the risk of respiratory distress syndrome, intraventricular hemorrhage and neonatal death among premature infants. No human randomized study has formally compared betamethasone and d...

What is the current status of trial NCT00418353?

This trial is currently completed. It is a NA study. The study started on 2002-08. Estimated completion is 2005-04.

What interventions are being tested in trial NCT00418353?

The interventions under investigation include: Betamethasone(Celestone soluspan) and Dexamethasone (DRUG).

Who is sponsoring clinical trial NCT00418353?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.